BETA
Dry-eye device company with a commercial warming system and the ELM development program.
Eyedetec Medical develops devices for dry-eye care. Its portfolio includes the EyeGiene Insta-Warmth system and the Eye Lipid Mobilizer (ELM), a separate program combining heat and mechanical action to address meibomian-gland dysfunction.
The company explicitly states that ELM is not currently available for commercial sale in the United States. EyeGiene has a different regulatory basis: a reviewed FDA letter identifies its disposable warming pack as Class I and exempt from premarket notification. That exemption does not authorize ELM or constitute FDA approval.
Barry Linder leads the company as president and CEO, supported by commercial and engineering executives. The profile separates the existing warming product from ELM launch preparation, with device-specific evidence and current U.S. availability kept distinct.
EyeGiene Insta-Warmth and the Eye Lipid Mobilizer are separate products. The reviewed listing/exemption evidence for EyeGiene does not establish marketing authorization for ELM, whose U.S. launch remains unconfirmed. [11][7][12][10][9][1]
No matching FDA recall event was identified in the completed company/applicant, linked-identifier and product-name searches. [5][3]
Latest recorded source review: 2026-10-20.
Documented commercial product families.
Localized heat therapy using a disposable warming pack. [7][8][12]
Exemption documentedCommercially offered; exact model and country availability should be confirmed with the manufacturer.
ELM U.S. launch remains unestablished; EyeGiene exemption is separate from the ELM program. [11][7][12]
Thermal and mechanical approach to meibomian-gland dysfunction; U.S. launch not established. [11]
Investigational / in developmentInvestigational only; not commercially available.
Accessed 10/20/2026